NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells.

Zhuang, Xiaoxuan; Long, Eric O

Zhuang, Xiaoxuan; Long, Eric O.

Affiliation

Zhuang X; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, United States.
Long EO; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, United States.

Front Immunol ; 13: 840844, 2022.

Article in En | MEDLINE | ID: mdl-35585985

Subject(s)

Neoplasms; Receptors, Chimeric Antigen; Adoptive Transfer; CD28 Antigens; Cytotoxicity, Immunologic; Humans; Immunotherapy, Adoptive; Killer Cells, Natural; Neoplasms/therapy; Receptors, Chimeric Antigen/genetics

Key words

chimeric antigen receptor; immunotherapy; inhibitory receptor; natural killer cell; tumor cell

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google